Cluny Capital Corp. Closes Financing TORONTO, June 06,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
90
Cluny Capital Corp. Closes Financing

TORONTO, June 06, 2018 (GLOBE NEWSWIRE) -- Cluny Capital Corp. (the “ Company ”) (TSXV:CLN.H), a capital pool company pursuant to Policy 2.4 of the TSX Venture Exchange (the “ TSXV ”), is pleased to announce it has closed its previously announced non-brokered private placement. The Company raised gross proceeds of $300,000 through the issuance of 6,000,000 common shares at a price of $0.05 per share. All shares issued pursuant to the financing are subject to a four-month hold period. The financing is subject to final approval by the TSXV. The net proceeds will be used by the Company for working capital and the identification and evaluation of a Qualifying Transaction (as such term is defined by the TSXV). In connection with the private placement the Company paid finder’s fees of an aggregate of $16,400.

Including the issuance of shares detailed in this news release, there are now currently 9,233,700 common shares of the Company issued and outstanding.

The common shares of the Company will commence trading on the TSXV at the open of trading on June 11, 2018.

The Company received subscriptions from its four new officers and directors for an aggregate amount of $25,000 for 500,000 common shares. The subscriptions by the new officers and directors result in "related party transactions" as defined under Multilateral Instrument 61-101 (“MI 61-101”). The transactions are exempt from the formal valuation requirements of MI 61-101 as none of the securities of the Company are listed on a prescribed stock exchange. The transactions are exempt from the minority shareholder approval requirements of MI 61-101 based on the financial hardship exemption.

In accordance with Policy 2.4, 1,300,000 common shares acquired by Non-Arm’s Length Parties (as such term is defined by the TSXV) have been placed in escrow pursuant to a TSXV Form 2F Escrow Agreement .

The Company also announces the completion of two securities for debt transactions with two arm’s length service providers. Pursuant to the transactions the Company issued an aggregate of $56,500 of unsecured convertible debentures in satisfaction of $56,500 of indebtedness. The convertible debentures, which mature on June 6, 2019 and accrue interest at 6% per annum, are automatically convertible into an aggregate of 941,666 common shares of the Company at a deemed price of $0.06 per share concurrent with the closing of a Qualifying Transaction. The Company determined to satisfy the indebtedness with convertible debentures in order to preserve its cash for use on working capital and the identification and evaluation of a Qualifying Transaction. The convertible debentures issued in satisfaction of the indebtedness are subject to a four month hold period from the date of issuance.

The Company also announces the grant of 450,000 stock options to the new management of the Company at an exercise price of $0.06 per common share expiring on June 6, 2028. Pursuant to approval of the TSXV, the directors of the Company have amended the stock option plan of the Company to remove the cap on the number of common shares to be reserved under the option plan from 10% of the number of common shares issued and outstanding at the time of the Company’s initial listing on the TSXV to 10% of the number of common shares of the Company issued and outstanding at the time of the grant.

Forward-Looking Statements

Certain statements contained in this news release constitute "forward-looking information" as such term is defined in applicable Canadian securities legislation. The words "may", "would", "could", "should", "potential", "will", "seek", "intend", "plan", "anticipate", "believe", "estimate", "expect" and similar expressions as they relate to the Company, are intended to identify forward-looking information. All statements other than statements of historical fact may be forward-looking information. Such statements reflect the Company's current views and intentions with respect to future events, and current information available to the Company, and are subject to certain risks, uncertainties and assumptions. Material factors or assumptions were applied in providing forward-looking information. Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize. These factors include, without limitation: changes in law; the ability to implement business strategies and pursue business opportunities; state of the capital markets; the availability of funds and resources to pursue operations; as well as general economic, market and business conditions, as well as those risk factors discussed or referred to in disclosure documents filed by the Company with the securities regulatory authorities in certain provinces of Canada and available at www.sedar.com . Should any factor affect the Company in an unexpected manner, or should assumptions underlying the forward looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking information included in this news release is made as of the date of this news release and the Company undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cluny Capital Corp. Michael Frank Chief Executive Officer (416) 482-3282 mfrank@datametrex.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 8

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 12

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 19

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 19

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 17

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 9

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 11

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading

Top 5 Most Recently Viewed Articles

ASP Isotopes Inc. Investors Urged to Join Class Action Lawsuit

Updated Category News Views 135

Class Action Lawsuit Announced for ASP Isotopes Investors ASP Isotopes Inc. has recently found itself in the midst of a class action lawsuit that many investors might want to pay attention to. This lawsuit has been initiated by Bronstein, Gewirtz & Grossman, LLC, a well-regarded law firm specializing in securities fraud. Investors whose financial interests have suffered...

Continue Reading
Boeing and Korean Air Announce Historic $36 Billion Purchase

Updated Category News Views 136

Boeing Secures Major Deal with Korean Air Boeing Co. (NASDAQ: BA) has entered into a remarkable $36.2 billion agreement with Korean Air. This historic deal encompasses the purchase of 103 aircraft, a strategic move coinciding with efforts to bolster American business interests internationally. Details of the Agreement and Fleet Modernization Announced recently, this...

Continue Reading
Debbie's Dream Foundation Launches 2026 Youth Art Contest

Updated Category News Views 20

Young Artists Called to Inspire a Cancer-Free World What's the first image that pops into your head when you think of a world free from cancer? That's the magic question on deck for this year's Youth Art Contest by Debbie's Dream Foundation. Imaginations are set to run wild as the competition opens its gates to artists under 18, calling for visions splashed across...

Continue Reading
European Stocks Surge Amid Easing Middle East Tensions

Updated Category News Views 67

European Markets Rally on Positive Sentiment European stock markets experienced a modest rise recently, primarily driven by the easing geopolitical tensions in the Middle East. This optimism comes at a crucial time as investors prepare for a week filled with potential market influences. As of early trading, Germany's DAX index climbed by 0.3%, while France's CAC 40 saw an...

Continue Reading
XPeng's Middle East Plans and the EV Landscape Ahead

Updated Category News Views 185

A Week of Mixed Developments in the EV and Travel Sectors This week marked a significant moment in the tech and travel sectors, showcasing both opportunities and challenges. Chinese electric vehicle (EV) manufacturer XPeng Inc. has announced its ambitious expansion plans aimed at the Middle East and Africa. This strategic move aligns with China's broader goals of...

Continue Reading